These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8495491)

  • 41. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
    Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
    J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway.
    Zimmermann VS; Rovere P; Trucy J; Serre K; Machy P; Forquet F; Leserman L; Davoust J
    J Immunol; 1999 Mar; 162(5):2495-502. PubMed ID: 10072488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitope-specific enhancement of antigen presentation by invariant chain.
    Momburg F; Fuchs S; Drexler J; Busch R; Post M; Hämmerling GJ; Adorini L
    J Exp Med; 1993 Oct; 178(4):1453-8. PubMed ID: 7690835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The I-Ab-restricted alloresponse of D10.G4.1 T cells is based on the recognition of an endogenous peptide.
    Gradehandt G; Kleber N; Mattner F; Milbradt S; Rüde E
    Immunology; 1993 Apr; 78(4):592-9. PubMed ID: 8495978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
    J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective processing of exogenous antigens by antigen-presenting cells with deleted MHC genes.
    Diment S; Shinde S
    J Immunol; 1995 Jan; 154(2):530-5. PubMed ID: 7814866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
    Gombos I; Detre C; Vámosi G; Matkó J
    Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules.
    Adams S; Albericio F; Alsina J; Smith ER; Humphreys RE
    Arzneimittelforschung; 1997 Sep; 47(9):1069-77. PubMed ID: 9342425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
    Diebold SS; Cotten M; Koch N; Zenke M
    Gene Ther; 2001 Mar; 8(6):487-93. PubMed ID: 11313828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
    Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
    Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells.
    Eisenlohr LC; Gerhard W; Hackett CJ
    J Immunol; 1988 Oct; 141(8):2581-4. PubMed ID: 2459219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.